PDCD1 and neoplasm: Working on the inhibitory receptor/ligand combinations between T-cells and tumor cells, such as the programmed cell death protein-1 (PD-1) and programmed cell death-ligand 1 (PD-L1), and the cytotoxic T lymphocyte antigen-4 (CTLA-4/B7) [14,15].